Archived from the original on November 13, 2013
Trial data generally shows: Mounjaro: 15-20% body weight reduction over 12-18 months Ozempic: 10-15% body weight reduction over a similar period If weight is the primary driver not just blood sugar Mounjaros dual-hormone mechanism gives it an edge for most patients
Rather than waiting months for an in-person appointment, Found unlocks access to board-certified medical professionals trained in obesity medicine right away
Together, they produce a stronger, more sustained GH pulse than either peptide alone without spiking cortisol or prolactin, which can actually disrupt sleep
Key Benefits: More physiologic growth hormone pulses Reduced risk of side effects Often used in combination with GHRP peptides (like Ipamorelin or GHRP-2) for synergistic release Flexible dosing (often 5 days/week) Half-Life: ~30 minutes to 2 hours , depending on formulation and injection site CJC-1295 With DAC: The Extended-Release Option When CJC-1295 is formulated with DAC , its half-life extends up to 8 days , allowing for once-weekly dosing